Clinitech Laboratory Limited IPO
- IPO Date25 Jul, 2024 to 29 Jul, 2024
- Listing Date01 Aug, 2024
- Face Value₹10 per share
- Issue Price₹96 to ₹96 per share
- Lot Size1200 Shares
- Minimum Investment₹1,15,200
- Listing AtBSE SME
- Total Issue Size6,02,400 Shares
(aggregating up to ₹5.78 Cr) - Fresh Issue6,02,400 Shares
(aggregating up to ₹5.78 Cr)
- Offer for Sale-
- Issue TypeFixed Price Issue IPO
- Share holding pre issue16,80,000
- Shareholding post issue22,82,400
IPO Dates
Closing Date
29 Jul, 2024
Initiation of Refunds
31 Jul, 2024
Listing Date
01 Aug, 2024
25 Jul, 2024
Opening Date
30 Jul, 2024
Basis of Allotment
31 Jul, 2024
Credit of Shares
Clinitech Laboratory Limited Lot Size
Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,15,200 |
| B-HNI (Min) | - | - | - |
| S-HNI (Max) | - | - | - |
| S-HNI (Min) | 2 | 2400 | ₹2,30,400 |
| Retail (Max) | 1 | 1200 | ₹1,15,200 |
Clinitech Laboratory Limited Promoter Holding
Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak are the promoters of the company.
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 83.63% | 61.56% |
Clinitech Laboratory Limited COMPANY INFORMATION
Clinitech Laboratory IPO is a fixed price issue of Rs 5.78 crores. The issue is entirely a fresh issue of 6.02 lakh shares. Clinitech Laboratory IPO opens for subscription on July 25, 2024 and closes on July 29, 2024. The allotment for the Clinitech Laboratory IPO is expected to be finalized on Tuesday, July 30, 2024. Clinitech Laboratory IPO will list on BSE SME with tentative listing date fixed as Thursday, August 1, 2024. Clinitech Laboratory IPO price is ₹96 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹115,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹230,400. First Overseas Capital Limited is the book running lead manager of the Clinitech Laboratory IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Clinitech Laboratory IPO is Svcm Securities. Refer to Clinitech Laboratory IPO RHP for detailed information.
Clinitech Laboratory Limited was founded in 1990 and provides diagnostic and health testing and services.
The company performs more than 150 tests in its centers, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.
Clinitech Laboratory has 8 diagnostic centers in and around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
The company's medical testing facilities at Airoli, Navi Mumbai have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
As of May 31, 2024, the company employed 85 people in various departments.
Summary of Clinitech Laboratory Limited IPO
Clinitech Laboratory Limited is launching its Initial Public Offering (IPO) of 6,02,400 equity shares at ?96 each, aggregating to ?578.30 lakhs. This is a fixed price offer. The company’s post-offer paid-up capital will be more than ?10.00 crore, making it eligible under SEBI's (ICDR) Regulations, 2018.
Key Details of Clinitech Laboratory Limited IPO
- IPO Size: 6,02,400 equity shares at ?96 each.
- Total Offer: ?578.30 lakhs.
- Promoters: Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak.
- Risks:
- This is the company's first public offer.
- No assurance of active or sustained trading post-listing.
- Investments in equity are subject to market risks.
- Listing: The shares will be listed on the SME Platform of BSE Limited.
- Offer Dates: Opens on July 25, 2024, and closes on July 29, 2024.
- Lead Manager: Inventure Merchant Banker Services Private Limited.
- Registrar: Bigshare Services Private Limited.
Pros of Investing in Clinitech Laboratory Limited IPO
- Growth Potential: As a first-time public offer, there is potential for substantial growth and returns.
- Experienced Promoters: The promoters have significant experience and expertise in the industry.
- Strategic Listing: Listing on the SME platform of BSE can attract focused investors interested in small and medium enterprises.
- Clear Objectives: Funds from the IPO are earmarked for specific objectives that can enhance company growth.
Cons of Investing in Clinitech Laboratory Limited IPO
- Market Risks: Equity investments are subject to high market risks, and there's no guarantee of returns.
- Lack of Market History: Being a first-time public offer, there's no historical market data to predict future performance.
- Limited Investor Base: Listing on the SME platform may limit the investor base compared to main market listings.
- Volatility: The share price could be highly volatile due to limited liquidity in the SME platform.
FAQs About Clinitech Laboratory Limited Ipo
Clinitech Laboratory Limited IPO will open on 25 Jul, 2024 and close on 29 Jul, 2024. Investors must apply within this period to participate.
The Clinitech Laboratory Limited IPO price band is set between ₹96.00 and ₹96.00 per share. The minimum lot size is 1200, requiring an investment of at least ₹115200.00.
The Clinitech Laboratory Limited IPO shares are expected to be listed on 01 Aug, 2024, subject to regulatory approvals and final allotment.
You can track your Clinitech Laboratory Limited IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Clinitech Laboratory Limited IPO will be listed on major stock exchanges such as BSE, where you can trade shares once they are listed.